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Abstract 
Background 
Glioblastoma (GBM) is a highly aggressive incurable brain tumor. The main cause of mortality in GBM 
patients is the invasive rim of cells migrating away from the main tumor mass and invading healthy parts 
of the brain. Although motion is driven by forces, our current understanding of the physical factors 
involved in glioma infiltration remains limited. This study aims to investigate the adhesion properties 
within and between patients’ tumors on a cellular level and test whether these properties correlate with cell 
migration. 
Methods 
Six tissue samples were taken from spatially separated sections during 5-aminolevulinic acid (5-ALA) 
fluorescence guided surgery. Navigated biopsy samples were collected from strongly fluorescent tumor 
cores, a weak fluorescent tumor rim, and non-fluorescent tumor margins. A microfluidics device was built 
to induce controlled shear forces to detach cells from monolayer cultures. Cells were cultured on low 
modulus polydimethylsiloxane representative of the stiffness of brain tissue. Cell migration and 
morphology were then obtained using time lapse microscopy. 
Results 
GBM cell populations from different tumor fractions of the same patient exhibited different migratory and 
adhesive behaviors. These differences were associated with sampling location and amount of 5-ALA 
fluorescence. Cells derived from weak- and non-fluorescent tumor tissue were smaller, adhered less well, 
and migrated quicker than cells derived from strongly fluorescent tumor mass. 
Conclusion 
GBM tumors are biomechanically heterogeneous. Selecting multiple populations and broad location 
sampling are therefore important to consider for drug testing.  
 
Keywords: glioblastoma, cell-matrix adhesion, cell migration  
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Key points 
GBM tumors are biomechanically heterogeneous 
GBM cell migration is inversely correlated with cell-matrix adhesion strength 
5-ALA fluorescence intensity during surgery correlates with the motility properties of GBM cells  
 
Importance of the study 
This study shows a clear correlation between the mechanical behaviour of patient derived tumour cells and 
intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA). Using a novel microfluidics 
approach, we measure cell-matrix adhesive forces (within and between tumor samples) and suggest a 
biophysical relationship between the characteristics of GBM cells and tumor spatial structure. Cells 
derived from the weak fluorescent tumor rim, and non-fluorescent tumor margins have different adhesion 
profiles and are highly migratory compared to those found in the core of the tumor. Not accounting for 
internal sampling location within each tumor obscures differences in cell morphology, motility and 
adhesion properties between patients. Preclinical tests aimed at developing a treatment for GBM using 
anti-invasive drugs or adhesion inhibitors, would benefit from using cell lines derived from the tumor 
periphery (with low 5-ALA intensity) rather than cell lines derived from the tumor core.  
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Introduction  
Glioblastoma (GBM) is the most common and the most malignant brain tumor. No cure is available 
despite significant improvements in surgical techniques and radiation technology. The extensive and 
infiltrative growth pattern of GBM makes surgical resection extremely difficult 1 and limits the efficacy of 
radiation therapy by obscuring tumor margins 2. Tumor recurrence is inevitable; targeted chemotherapy 3 
and immune therapy 4 have failed to stop tumor recurrence. 
 
Migration and invasion are driven by mechanical forces 5. The mechanical properties of a GBM tumor and 
its microenvironment have also shown to contribute to tumor invasion 6,7. GBM employ a mesenchymal 
mode of migration 8 using focal adhesions proteins as molecular clutches to transmit forces to their 
environments. Targeting  integrins or kinases that mediate cell-matrix adhesion has therefore been 
explored as a strategy to inhibit tumor growth (e.g. focal adhesion kinase (FAK) inhibitor 9) or to halt the 
mesenchymal mode of migration employed by infiltrating GBM cells10.  However, therapeutics designed to 
target adhesion receptors or proteases have failed in clinical trials 11, particularly in gliomas (e.g. 
cilengitide 12). This failure might be due to the heterogeneity in expression of the adhesion proteins in 
glioma. Arguably GBM intratumor heterogeneity is the key to understanding treatment failure 13 and 
infiltration. 
 
GBM tumors show transcriptomic and genomic distinct subclasses 14,15 which vary across patients, but also 
across individual cells within a tumor 16. This could explain why gene expression-based molecular 
classification of brain tumors failed to provide a more accurate prediction of tumor progression and 
response to treatment. Differential response to treatment is visible during fluorescent guided surgery. GBM 
cells glow fluorescent pink when 5-aminolevulinic acid (5-ALA) is administered orally prior to surgery. 
The heterogeneity of 5-ALA-induced PpIX fluorescence observed during surgery was associated with 
different cellular functions and a distinct mRNA expression profile, where non-fluorescent tumor tissue 
resembled the neural subtype of GBM and fluorescent tumor tissue did not exhibit a known subtype 17. 
However, whether fluorescence heterogeneity is mirrored by physical heterogeneity amongst GBM cells 
remains unclear.  
 
D
ow
nloaded from
 https://academ
ic.oup.com
/noa/article-abstract/doi/10.1093/noajnl/vdaa081/5867139 by guest on 13 July 2020
Ac
ce
pte
d M
an
us
cri
pt
 
6 
 
To investigate the different adhesive and migratory properties of GBM subpopulations, we derived tumor 
cells from different GBM patients, and from different regions within the same tumor. Tissue samples 
obtained from the same tumor were collected from spatially distinct locations with different 5-ALA 
fluorescent intensities. We adapted a microfluidic device for detachment of adherent cells through shear 
stress18,19. We demonstrate substantial intra- and inter-tumoral heterogeneity; adhesion strength varied 
tenfold (from 15 Pa to 150 Pa). Cells from the weak fluorescent tumor rim and non-fluorescent margins 
were smaller, less adherent with highly migratory behavior, suggesting that differential adhesion and 
migration speed between subpopulations of cancer cells may contribute to tumor invasion. Such 
heterogeneity could also explain recently observed diff erential responses of patients to adhesion-blocking 
drugs.   
 
Materials and Methods 
Sample collection 
Tissue collection protocols complied with the UK Human Tissue Act 2004 (HTA license ref. 12315) and 
have been approved by the local regional ethics committee (LREC ref. 04/Q0108/60).Tissue samples were 
derived from newly diagnosed GBM patients who underwent their first surgical resection at 
Addenbrooke's, Cambridge University Hospitals. Aminolevulinic acid (5-ALA) fluorescence was orally 
administered four hours before induction of anesthesia at a dosage of 20 mg/kg.  Three different regions 
within the tumor were biopsied. Six tissue samples from two different patients were taken from spatially 
separated sections using MRI stealth imaging. Navigated biopsy samples were collected from strongly 
fluorescent tumor cores, a weak fluorescent tumor rim, and non-fluorescent tumor margins (Figure 1A).  In 
addition, three tissue samples from a third patient were collected from similar locations (results described 
in supplementary material). The patient’s clinical information and their molecular biomarker status (IDH 
mutation and MGMT promoter methylation) can be found in Supplementary Table 1. 
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Derivation of GBM stem-like cells  
Cell derivation and maintenance have previously been described20. Briefly, tissue was mechanically 
minced and enzymatically dissociated before passing through a 40 µm cell strainer. Cells were seeded in 
serum-free medium (SFM) (phenol red free Neurobasal A) with 2mM l-glutamine and 1% volume/volume 
(v/v) penicillin/streptomycin (PS) solution with 20 ng/mL human epidermal growth factor, 20 ng/mL 
zebrafish fibroblast growth factor (FGF-2), 1% v/v B27 SF supplement, and 1% N2 SF supplement. Cells 
were allowed to form primary aggregates. Spheroid aggregates were collected and plated, onto Engelbreth-
Holm-Swarm sarcoma extracellular matrix (ECM, Sigma)–coated flasks (ECM 1:10 dilution with HBSS) 
and allowed to form a primary monolayer. When the primary monolayer reached 80% confluency, cells 
were passaged to generate the subsequent monolayers by mechanically and enzymatically dissociating 
remaining aggregates.  Cells were maintained at 37°C and 5% CO2. Experiments were performed using 
passages 3-9. Cell lines were screened regularly for mycoplasma.  
Immunocytochemistry  
Cells were seeded in duplicates into µ-Dish 35 mm (60,000 cells/ibidi dish). After 48 hours, cells were 
washed with sterile phosphate buffered saline (PBS, Thermo Fisher) before being fixed in 4% 
paraformaldehyde for 30 minutes (10 minutes at 4°C followed by 20 minutes at room temperature). Cells 
were washed and then permeabilized for 4 minutes in 0.2% Triton in PBS. Cells were washed again and 
incubated in blocking buffer (1% bovine serum albumin (BSA), and 2% normal goat serum (NGS), in 
PBS) for 1 hour at room temperature before incubating with the primary antibody for 2 hours. The 
following primary antibodies were used: Nestin (Abcam, ab22035, 1:100), Vimentin (Abcam, ab8069, 
1:200), NG2 (Abcam, ab83178, 1:200), Ki67 (Abcam, ab16667, 1:200), Vinculin (FAK100, Sigma 1:200), 
F-actin (FAK100, Sigma 1:500). Secondary antibodies were applied for 1 hour (goat anti-mouse Alexa 
Fluor 488 pre-adsorbed abcam, 1:750 dilution and goat anti-rabbit Alex Fluor 594 pre-adsorbed abcam, 
1:750). Nuclei were stained with DAPI (Roche) 
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Immunoblotting 
Cell lysis was performed using cOmpleteTM, EDTA-free lysis-M buffer with protease inhibitor (Roche). 
Protein concentrations were determined using PierceTM BCA kit (Thermo ScientififTM). Equivalent 
amounts of protein were electrophoresed on SDS-polyacrylamide gels. The gels were then electroblotted 
onto PVDF membranes. After blocking with Odyssey Blocking Buffer (TBS) (LI-COR), membranes 
where incubated with the primary antibody overnight (Paxilin, Vinculin, FAK, GAPDH (codes need to be 
looked up at home). Finally, the relevant protein was visualized by staining with the appropriate IgG H&L 
secondary antibody coupled to either IRDye® 800CW or IRDye® 680RD. The antigen of interest was 
detected using the LI-COR Odyssey CLx Infrared Imaging System. Results were analysed using 
ImageStudio. 
Poly-di-methyl-siloxane (PDMS) substrates for studying cellular motility and morphology 
NuSil GEL-8100 (NuSil) was prepared in a 1:1 ratio of component A and component B and mixed well for 
60 seconds. 1% (w/w) 10:1 (base/crosslinker w/w) Sylgard-184 (VWR) was added to the GEL-8100 and 
mixed well for 60 seconds. For cell morphology experiments approximately 120mg of the PDMS was 
added to µ-Dish 35 mm (120mg/dish). For cell migration experiments 80mg/well of PDMS was added to 
24-well culture plates (Corning Life Science, Tewksbury, MA, USA). Coated vessels were baked at 65◦C 
for 13 hours. This treatment gave a shear modulus value of G =1.53±0.12 kPa, n = 16, verified by atomic 
force microscopy (AFM) indentation. The AFM setup consisted of a JPK CellHesion 200 scanner, and the 
indentation probe was made by gluing a spherical polystyrene particle (90 um diameter), to a tipless AFM 
probe (SHOCON-TL, k ~ 0.1 N/m). Vessels were sterilized by immersion in 70% (v/v) ethanol in distilled 
water for 15 minutes, followed by two rinses with PBS. The PDMS surface was coated with ECM at a 
concentration corresponding to a surface density of 6.67 µg/ml assuming complete adsorption.  
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Cell detachment assay 
Microfluidic devices were manufactured (Supplementary information S1) and sterilized by immersing in 70% 
ethanol in distilled water (v/v) in a Petri dish, and perfusing with the same liquid at 10 mL/h for 30 minutes. The 
devices were lifted from the ethanol and perfused with phosphate-buffered saline (PBS, Thermo-Fisher) at 5 
mL/h for 1 hour to rinse the ethanol and allow PBS to permeate the bulk of the device. The devices were filled 
with 200 µg/mL ECM matrix and placed in the incubator overnight (approximately 16 hours). SFM was 
equilibrated overnight in the incubator to minimize bubble formation. Cells were detached as described 
previously and resuspended to a concentration of 3.5x10^6 cells/mL. Cells were loaded into 1mL syringes and 
perfused into the devices at 30 µL/h for 5 minutes. Perfusion was resumed for 3 minutes with the inlet and outlet 
reversed to seed cells evenly. The devices were placed in the incubator for 4 hours to promote cell attachment. 
The devices were then perfused for 20 hours with equilibrated SFM at a flow rate of 10 µL/h to allow cells to 
fully spread 21-23. For cell detachment, neurobasal Medium without supplements was also equilibrated overnight 
in the incubator to minimize bubble formation and to control dissolved gas concentration and pH. Cells were 
subjected to a steady flow rate  of 0.16 mL/min, 0.33 mL/min and 0.5 mL/min to create a constant shear force 
on the cell (Supplementary information S1).Phase-contrast images of a single field of view were taken every 
two seconds at 160×magnification (Zeiss Axio Observer.Z1). The maximum flow rate used was 0.5 mL/min, (a 
shear stress of 75.96 Pa), although shear stress of up to 506 Pa is achievable with the system, limited by the 
maximum flow rate of the syringe pump. 
Time lapse measurements and cell tracking analysis  
Cells were cultured in 24-well culture plates (Corning Life Science, Tewksbury, MA, USA) according to 
the manufacturer’s instructions and visualized using a real-time cell imaging system (IncuCyte™ live-cell 
ESSEN BioS ience Inc, Ann Arbor, Michigan, USA). Ten thousand cells/well were cultured on PDMS 
substrate of 1.5 kPa stiffness. Cells were seeded in triplicates and imaged every 10 min for 48 hours. Time-
lapse images were acquired with IncuCyte, a live cell imaging microscope. 
Raw images were processed in CellProfiler24 to detect cell outlines. Cells were tracked using automated 
tracking in TrackMate25. Cell area was calculated after 24 hours , using the hierarchical K-means 
thresholding module in Icy26. The mean square displacement (MSD) of each cell from its starting position 
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was calculated. The MSD of actively moving cells should be larger than the expected MSD of a freely 
diffusing (Brownian) particle of comparable size: 
𝑀𝑆𝐷 >
𝐾𝐵𝑇
3 𝜋 𝜂 𝑟
 𝑡 
where 𝐾𝐵  is the Boltzmann constant, 𝑇 = 310 K the absolute temperature, 𝜂 the viscosity of the medium, 𝑟 
the radius of the cell and 𝑡 the time interval. We assumed the viscosity of the medium to be 𝜂 ≈ 0.78 mPa 
s.  
Statistical analysis 
Data were verified from at least two independent biological experiments. For experiments involving 
single-cell analysis, n ≥ 100 cells. The order of data collection was randomized; no blinding was performed 
and no data were excluded from the analysis.  
Morphological differences between patients and fluorescence groups were tested using linear regression. 
First, we tested differences between patients and differences between fluorescence groups independently. 
Then we tested for differences simultaneously using an additive model (for patients and fluorescence 
intensity).  Since there was no statistically significant difference between weak- and non-fluorescent cell 
lines but both were different from strongly fluorescent cell lines, we pooled the weak- and non-fluorescent 
groups. To check whether sampling from multiple locations violated our standard linear model 
assumptions, we tested unexplained heterogeneity using mixed effect regression. Including a random effect 
of all lines did not significantly improve model fit. This indicates that a mixed effect model is not required.  
Adhesion heterogeneity between cell lines was analyzed using Welch’s t-test (unequal variance) with 
Bonferroni correction (15 comparisons). The shear stress required for 50% cell detachment was found by 
performing an orthogonal distance regression, and the resulting fitted values and associated standard errors 
were used in the Welch’s t-test formula. Differences in cell migration between patients and fluorescence 
groups were tested using weighted linear regression (using MSD slope estimate as the outcome). First, we 
tested differences between patients and differences between fluorescence groups independently. After 
pooling the weak- and non-fluorescent cell lines, we tested for differences simultaneously using an 
additive model (for patients and fluorescence intensity).  
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Statistical analyses and plotting were performed in Python 3.6, MATLAB or R statistical software 
package. 
 
Results 
Relationship between tissue fluorescence heterogeneity and GBM cell morphology  
Primary GBM cell lines maintained in serum-free media expressed neural stem cell markers nestin and 
vimentin (Figure 1B). This confirmed the presence of glioma stem-like cells which are regarded as 
tumorigenic and associated with the heterogeneity in GBM 27 . We then investigated the cell spreading area 
which is known to be an indicator of how cells mechanically interact with their extracellular 
environment28.  
Cells were cultured on polydimethylsiloxane, with a low modulus consistent with the stiffness of the 
environment that GBM infiltrate, which ranges from 0.1 kPa to 10 kPa 29 . Glioma cells are known to 
spread on substrates of stiffness around 1kPa30However, on extremely compliant substrate (~150 Pa) GBM 
cells exhibit rounded morphologies with diffuse distributions of F-actin that are unable to migrate 
productively31. To compare between lines, we used a single stiffness, ~1.5kPa (Methods) (Figure 1C).  
 
To explain the variability in cell morphology observed among patients’ cell lines (Figure ID), we first 
tested whether cells from patient A differed from those of patient B.  Cells derived from patient A 
exhibited a more elongated morphology compared to cells derived from patient B (***p < 0.001), but there 
was no significant difference in cell area (p=0.1). However, cells derived from strongly fluorescent lines 
differed significantly in cell area and cell elongation between patients (***p < 0.001). We therefore 
adjusted our model to account for fluorescence intensity when comparing between patients (Methods). We 
found that cells from patient A were both larger and more elongated than cells derived from patient B 
(***p<0.001).  
 
The results demonstrate morphological differences within each tumor and between tumors and show that 
this heterogeneity is related to 5-ALA fluorescence intensity. Not accounting for this variability obscured 
the difference between patients. To investigate whether the differences in cell morphology relate to the 
D
ow
nloaded from
 https://academ
ic.oup.com
/noa/article-abstract/doi/10.1093/noajnl/vdaa081/5867139 by guest on 13 July 2020
Ac
ce
pte
d M
an
us
cri
pt
 
12 
 
way cells adhere to their environment, we explored whether heterogeneity in cell area and shape correlate 
with specific patterns of key cytoskeletal proteins.  
 
The organisation of actin filaments and vinculin suggests intertumoral heterogeneity in GBM cell-
matrix adhesion  
Actin filament disassembly is required for cell spreading, and the binding to proteins such as paxillin and 
vinculin is necessary for focal adhesion development 32. We imaged the localization and structure of actin 
filaments and the actin binding protein vinculin. The shape and distribution of actin and vinculin differed 
between cells derived from strongly fluorescent lines and cells derived from weak- and non-fluorescent 
lines. The colocalization of vinculin with F-actin was evident at the edge of cells derived from strongly 
fluorescent lines (Figure 2A). Adhesion proteins paxillin, vinculin and Focal Adhesion Kinase (FAK) were 
expressed across all cell lines (Supplementary Figure S1), but their expression levels did not reflect the 
arrangements and assemblies revealed in immunocytochemical images. The binding of vinculin to F-actin 
suggests spatial differences in focal adhesion assembly and enlargement within the tumor. We therefore 
built a set-up to quantify the intra-and-inter tumoral heterogeneity in cell-matrix adhesion.  
 
Cell-matrix adhesion heterogeneity within and between patient-specific tumor samples  
To quantify adhesion strength within GBM cell population, we built a microfluidic device that supported 
overnight culture of GBM cells and generated sufficient shear force to trigger cells detachment 
(Supplementary Figure S2). Patients’ derived cells were delivered into the channels via syringe pumps 
(3.5x106cells /mL). Cells were gently perfused with serum free medium and placed in an incubator for 24 
hours to allow adhesion to fully establish and cells to fully spread 21-23 . Cells were subjected to a 
controlled flow rate to create a constant shear force on the cell (Supplementary information S1). The 
fraction of detached cells was measured over time (Figure 3A). We consistently found an initial phase of 
rapid detachment followed by a second phase of slower detachment (Figure 3B), consistent with previous 
parallel-plate and microfluidic detachment assays 33,34. This transition manifests itself in most experiments 
as a “knee” in the time-detachment curve after the first 5 to 10 minutes of exposure to the shear force 
(Supplementary Figure S3). 
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There is some evidence suggesting that the second phase is a result of adhesion weakening in response to 
imposed flow, driven by Rho regulation of focal contact maturation and turnover 35,36. As a consequence, 
cell detachment measurements taken later in time may not be representative of cell-matrix adhesion under 
normal condition. We chose to take measurements of detachment at 5 minutes of flow, as a quantification 
of adhesion strength (Supplementary Figure S3).  
Detachment at 5 minutes was expressed as a fraction of the cell number at t=0. Detachment fraction as a 
function shear stress was fitted to a logistic function, and the shear stress required for 50% detachment (τ𝑑) 
was identified. as the inflection point of the logistic fit (Figure 3C). τ𝑑 ranged between 15 Pa and 141 Pa. 
This range is consistent with microfluidic single-cell adhesion strength measurements of 3T3 fibroblasts, 
which fell between 20 and 220 Pa19. 
Cells derived from weak- and non-fluorescent cell lines had significantly lower cell-matrix adhesion than 
cells derived from strongly fluorescent cell lines across patients A and B (*p < 0.05) (Figure 3D), and 
smaller cell spreading area (Figure 3E). The mean value of detachment strength of patient B was 
significantly higher than that of patient A (**p = 0.005). The data shows that both intra- and inter-tumoral 
cell-matrix adhesion heterogeneity is present within GBM.   
 
Migratory behavior of tumor derived cell populations is predicted by adhesive forces  
To measure the migratory behavior of GBM cells, we recorded their trajectory on a compliant PDMS 
substrate. Their movement is stochastic at the scale of 10 mins and is best characterized by an effective 
diffusion coefficient D which capture the rate of change of the squared end-to-end distance travelled 
(Mean square displacement (MSD) ΔR2) as a function of time interval ΔT: ΔR2 = D ΔT. The larger D, the 
more migratory the cell line is.  
We tested for differences in diffusion coefficient D using an additive model (to account for patients and 
fluorescence intensities), see Methods, and found that cells from patient B migrated faster than patient A 
(*p<0.05). Cells derived from strongly fluorescent tissue samples were significantly slower than cells 
derived from weak- and non-fluorescent cell lines (**p < 0.01) (Figures 4A), had a larger area (Figure 4B) 
and higher adhesion strength (Figure 4C). This result is consistent with previous models of pseudopodial 
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migration, in which a certain level of adhesion is required for generation of traction forces, but excessive 
adhesion impedes motion 37. Additionally this observation suggested a potential mechanism for differential 
diffusion.  
 
Discussion 
In order to invade the surrounding tissue, GBM cells have to exert forces on their environment and 
mechanically interact with it. They also have to undergo biological and morphological changes that allow 
them to migrate through the perivascular spaces and white matter tracts of the brain 10. Instead of 
observing the tumor tissue in vivo, our approach isolated cell lines (from different tumor regions with 
different intraoperative 5-ALA-induced fluorescence intensities) and measured their adhesive and 
migratory properties under controlled conditions allowing direct comparison. The results are therefore not 
confounded by any spatial differences in extracellular matrix composition, nutrient and oxygen 
availability.  
 
. Our findings establish that patient-derived tumor cells have distinct adhesion profiles, that were 
reproducible and consistent over several passages (Figure 3B). These profiles were strongly associated 
with different migration behaviours, cell size (rather than shape Supplementary Figure S4), tissue sampling 
locations and strong vs weak 5-ALA fluorescence. The relationship was further confirmed by analysing a 
third patient whose tissue samples were obtained from three similar locations in the tumour; the derived 
cell lines exhibited similar morphology (Supplementary Figure S5), adhesive (Supplementary Figure S6) 
and migratory behaviour (Supplementary Figure S7). The migratory and adhesion properties of the cell 
lines were stable over several passages (Figure 4A, 3B, Supplementary Figure 6A, 7A) for the same 
microenvironment. This suggests that the observed biomechanical heterogeneity reflects specific cell 
populations rather than cellular plasticity as seen for the expression of various cell surface markers 
commonly used to define stem cell populations27,38. However, in order to validate this hypothesis, both cell 
lines and original tumour samples should be genetically tested and analysed for differences in their 
mutational and copy number landscape.   
D
ow
nloaded from
 https://academ
ic.oup.com
/noa/article-abstract/doi/10.1093/noajnl/vdaa081/5867139 by guest on 13 July 2020
Ac
ce
pte
d M
an
us
cri
pt
 
15 
 
 
The fact that adhesion strength is associated with reduced movement39 in vitro suggests a simple model 
where migratory forces must overcome adhesion forces to generate motion. This idea was tested 
numerically (Supplementary information S2) in order to relate MSD curves with the measured values of 
cell adhesion. This approach can be extended to simulate mixed populations of core and marginal cells. 
The variation in adhesion strength leads to variations in amount of migration, causing cells with lower 
adhesion to be predominant at the leading edge, consistent with the clinical observation (Supplementary 
Figure S8). This suggests that differential migration may play a role in the spatial distribution of cells 
within tumor. Differential migration is known to contribute to cell segregation40. GBM intratumoral cell 
proliferation is strongly associated with the fluorescence intensity of samples, and hence the spatial density 
and distribution of cells. 
Recently it has also been shown that fluorescent and non-fluorescent tissue samples can be distinguished 
genetically 17. Due to our controlled experimental conditions, much of the observed intra- and inter-
tumoral heterogeneity is likely to be of genetic or epigenetic origin, rather than caused by spatial 
differences in the original tissue’s microenvironment. A relationship between glioma mechanics, genetic 
profiles and epithelial-mesenchymal transition marker expression) and intraoperative techniques (e.g. 
5ALA intensities, stealth imaging), would provide a greater understanding of why specific tumour 
subtypes are more or less sensitive to current therapeutics.  
 
Our results are consistent with a broader picture of GBM as a genetically heterogeneous cancer 13,16. The 
human genome encodes 24 different integrin subunits41, which are highly heterogeneously expressed 
within GBM42-44. These integrins have varying degrees of cross-specificity in both the natural ECM 
ligands and synthetic inhibitor molecules they can bind. Our results and previous experimental 45 and 
theoretical work37 support the hypothesis that the migratory phenotype is linked with cell adhesive forces. 
Inhibition of one or a few integrins may not significantly change cell-adhesive forces, due to the 
aforementioned redundancy or compensation through feedback loops that may themselves be driven by 
cellular mechanosensing46. Integrin inhibitors for glioma therapy have been assessed primarily by their 
affinity and specificity for the target molecule and their ability to arrest tumour growth47. Our approach of 
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directly measuring adhesive provides an overall quantitative assessment the strength of cell adhesion that 
accounts for the presence of integrins and enables a direct correlation with migration data. 
 
 Patients’ differential response to adhesion inhibitors and anti-invasive molecular treatments maybe due to 
intrinsic differences in GBM cell motility, adhesion and traction forces. Preclinical tests of adhesion-
block typically  use only one or two tumor core cell lines, which may not be representative of the 
distribution of integrin expression and adhesion in GBM tumors. Given that integrins play a crucial role in 
brain tumor infiltration 48 and GBM intratumor variability in integrin expressions 49. New trials that aim to 
halt GBM recurrence by inhibiting radiation-induced invasion gains and signaling changes 10,50, or kinase 
inhibitors9, could benefit from accounting for intra-and-intertumoral differences in cell migration.  
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Figure 1: Fluorescence and Morphological Characteristics of GBM Patients Derived Cell Lines 
(A) White light image of resection cavity and corresponding fluorescence view of surgical field demonstrating 
the heterogeneous fluorescence pattern of 5-ALA (bright strong pink from tumor core, faint/weak pink from 
tumor rim, and non-fluorescent tumor margin). Intraoperative images were obtained via ZEISS OPMI 
PENTERO 800, with 39x magnification. We collected three strongly fluorescent tissue samples from the tumor 
mass (S from patient A, S1 and S2 from patient B), two non-fluorescent tumor margins (N1 and N2) from 
patient A, and one weak-fluorescent tissue sample (W) from patient B.  
(B) Immunofluorescence staining for evidence of GBM stem like cells. Neural stem cell marker nestin (green), 
and vimentin (green) are expressed in each cell line; scale bars 20 µm.  
(C) Representative phase-contrast images showing cells derived from strong fluorescent tissue samples has 
larger area compared to cells derived from weak- and non-fluorescent samples. Patient A exhibited a more 
elongated morphology compared to patient B (***p<0,.001); scale bars 100 µm. At least three independent 
experiments were carried out, with at least 360 cells analyzed per patient. Or/ Between 360 - 500 cells were 
analysed from at least three independent experiments per patient.  
(D) Morphological quantification of cells cultured on PDMS substrates of ~1.5kPa stiffness. Boxplots show 
spatial and intertumoral heterogeneity in cell area and cell elongation. Boxplots represent the “minimum”, first 
quartile (Q1), median, third quartile (Q3), and maximum. At least 110 (or Between 110-180 cells) cells were 
analysed from at least two independent experiments.  
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Figure 2. F-actin cytoskeleton and Vinculin proteins expression in GBM lines 
Confocal images showing the colocalization of vinculin and F-actin at the edge of cells derived from strong 
fluorescent lines compared to cells derived from weak- and non-fluorescent lines. Cells were stained with 
TRITC-phalloidin (red) to visualize the actin cytoskeleton, vinculin (green) and DAPI (blue). Scale bars 40 µm.  
 
Figure 3: GBM exhibits spatial and inter-tumor heterogeneity in cell-matrix adhesion.  
(A) Representative phase-contrast images of cells under microfluidic shear detachment at 0, 150, and 300 
seconds. Here BW cells are exposed to 0.33 mL/min of flow, corresponding to 51 Pa of shear stress. Scale bars 
100 µm. 
(B) For each condition (shear flow), detachment-time curve were generated using two independent experiments 
per cell line (25-138 cells per experiment).Detachment increases with shear stress, but the relative ordering of 
the lines remains constant except for cell line AS. Detachment initially occurs rapidly, and plateaus for most cell 
lines.  
(C) The inflection point of each sigmoidal curve was extracted to define τ𝑑 , a measurement for the cell-matrix 
adhesion strength of the cell lines.  
(D) Differences between weak- and strongly-fluorescent lines were statistically significant for all intra-patient 
pairs except BW and BS2 (one * indicates (*p <0.05) and additional *s indicates further orders of magnitude, 
under Welch’s t-test with Bonferroni correction). The mean value of τ𝑑for patient B was significantly higher 
than that of patient B (**p = 0.005). 
(E) Relationship between cell spread area and cell-matrix adhesion strength. Strong fluorescent cells are more 
adherent and larger than weak- and non-fluorescent cells.  Error bars represent SEM from at least two 
independent experiments.  
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Figure 4. Cell-matrix adhesion is an important factor for GBM cell migration  
(A) MSD as a function of time interval (Δt) calculated from cell trajectories with vertical bars representing 
standard errors. At least 100 cells were analysed from two independent experiments.. Having accounted for 
tissue fluorescence intensity, we found that cells from patient B migrated faster than patient A (*p<0.05). Cells 
derived from strongly fluorescent tissue samples were significantly slower than cells derived from weak- and 
non-fluorescent cell lines (**p < 0.01). 
(B)  Cells with larger cell area migrate less than those with smaller cell size derived from the weak- and non-
fluorescent samples. Error bars represent SEM from at least two independent experiments. 
 (C) Cells derived from strong fluorescent tissue samples are more adhesive and less migratory. Error bars 
represent SEM from at least two independent experiments. 
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Figure 1 
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Figure 2 
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Figure 3 
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Figure 4 
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